Generic Name nalbuphine

Trade Name Nubain

Class Opioid analgesics

Dose and Frequency

IVP RATE OF ADMIN.

TIME DUE PRN

Dizziness, headache, sedation,

MOST IMPORTANT dry mouth, nausea, vomiting,
Side Effects clammy feeling

Assess type, location, and

Nursing Interventions intensity of pain before
and 1 hr after IM or 30
min (peak) after IV
administration. Not
recommended for
prolonged use or as first-
line therapy for acute or
cancer pain.
Assess BP, pulse, and
respirations before and
periodically during
administration. If
respiratory rate is
<10/min, assess level of
sedation. Nalbuphine
produces respiratory
depression, but this does
not markedly increase
with increased doses.

Specific Reason pt Pain

receiving